Most studies to date suggest a tumour suppressive role for Cx26 early in breast cancer progression based on evidence that Cx26 is frequently absent or down-regulated in human breast cancer cell lines or human primary tumors [17, 19, 32]. The gene discussed is GJB2; the disease is breast cancer.